Targacept (TRGT)
Targacept Cash and ST Investments: 176.56M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TRGT Cash and ST Investments Rankings
| Overall | 65th percentile | 1516 of 4368 |
| Sector | 75th percentile | 125 of 506 in Healthcare |
| Industry | 77th percentile | 36 of 160 in Biotechnology |
TRGT Cash and ST Investments Range, Past 5 Years
| Minimum | 63.00M | Jun 2007 |
| Maximum | 285.09M | Mar 2010 |
| Average | 147.11M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these TRGT related companies
TRGT News
Listen to $TRGT Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f5M
about 29 days ago by earningscast
about 29 days ago by earningscast
Targacept (TRGT) to Reduce Workforce by 65; Clinical Development SVP Dunbar to Retire
Apr 25, 9:11AM Street Insider
Apr 25, 9:11AM Street Insider
Targacept Announces Reduction in Force and Plan to Focus Resources on Later-Stage Pipeline
Apr 25, 9:10AM Business Wire
Apr 25, 9:10AM Business Wire
Targacept to Report First Quarter 2012 Financial Results on May 3, 2012
Apr 24, 8:55AM Business Wire
Apr 24, 8:55AM Business Wire
$TRGT getting some interest after Barron’s noted that it could be long-ball stock triple. Stock is down 80% and has a poor record so far.
about 45 days ago by abubnic
about 45 days ago by abubnic
$TRGT very bullish Barron's article cites analyst looking for a triple..loaded with cash & multi-drug pipeline
about 45 days ago by drstock2008
about 45 days ago by drstock2008
$TRGT good potential here for modest gains - they have cash and active partner, and a nice pipe to boot http://stks.co/3Mpr
about 47 days ago by rickz
about 47 days ago by rickz
Targacept (TRGT) Reports ID Error in Revised Top-Line Results from TC-6987 Phase 2
Apr 10, 8:57AM Street Insider
Apr 10, 8:57AM Street Insider
Targacept (TRGT) revises top-line results from exploratory Phase 2 study of TC-6987 in asthma, found error in app
Apr 10, 8:56AM Street Insider
Apr 10, 8:56AM Street Insider
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of TC-6987 in Asthma
Apr 10, 8:55AM Business Wire
Apr 10, 8:55AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TRGT | 4.14 | -0.01 | -0.24% | 138.61M |
| TRGP | 42.53 | -1.81 | -4.08% | 1.878B |
| TRF | 12.80 | -0.39 | -2.96% | |
| TREX | 27.05 | -2.05 | -7.04% | 455.42M |
| TREE | 8.95 | -0.08 | -0.89% | 99.78M |
| TRC | 25.29 | -1.35 | -5.07% | 532.53M |
| TRAK | 25.75 | -1.55 | -5.68% | 1.145B |
| TCB | 10.99 | -0.80 | -6.79% | 1.910B |
| TCAP | 19.98 | -0.36 | -1.77% | 553.45M |
| TC | 3.44 | +0.01 | +0.29% | 576.51M |
